Skip to main content

Table 1 Demographic and clinical characteristics of all study participants

From: Support for lowering cervical cancer screening age to 25 for women living with HIV: retrospective cross-sectional programmatic data from Botswana

Variable

All

Age 25–29 years

Age 30–49 years

P-value for χ2 test

n (%)

Median [IQR]

na (%)

na (%)

Age

5714

35 [31, 39]

   

Smoking

5661

 

1018 (18.0)

4643 (82.0)

0.008b

Yes

285 (50.0)

 

68 (6.7)

217 (4.7)

 

No

5376 (94.1)

 

950 (93.3)

4426 (95.3)

 

Missing

53 (1.0)

    

Sexual debut

5689

18 [17, 21]

1024 (18.0)

4665 (82.0)

0.02b

 ≤ 18

3150 (55.3)

 

533 (52.1)

2617 (56.1)

 

 > 18

2539 (44.4)

 

491 (47.9)

2048 (43.9)

 

Missing

25 (0.4)

    

Parity

5612

2 [1, 3]

1001 (17.8)

4611 (82.2)

 < 0.001b

 ≤ 2

3223 (56.4)

 

815 (81.4)

2408 (52.2)

 

 > 2

2389 (41.8)

 

186 (18.6)

2203 (47.8)

 

Missing

102 (1.8)

    

HIV status

5583

 

989 (17.7)

4594 (82.3)

 < 0.001b

Negative

557 (9.7)

 

140 (14.2)

417 (9.1)

 

Positive

5026 (88.0)

 

849 (85.8)

4177 (90.9)

 

Missing

131 (2.3)

    

Initial CD4 at HIV diagnosisc

4475

250 [150, 428]

760 (16.9)

3715 (83.1)

 < 0.001b

 ≤ 350

2308 (45.9)

 

304 (40.0)

2004 (53.9)

 

 > 350

2167 (43.1)

 

456 (60.0)

1711 (46.1)

 

Missing

551 (11.0)

    

On ART at time of screeningc

4766

 

802 (16.8)

3964 (83.2)

 < 0.001b

Yes

1628 (32.4)

 

346 (43.1)

1282 (32.3)

 

No

3138 (62.4)

 

456 (56.9)

2682 (67.7)

 

Missing

260 (5.2)

    

VIA results

5714

 

1029 (18.0)

4685 (82.0)

 < 0.001b

Positive

1959 (34.3)

 

428 (41.6)

1531 (32.7)

 

Negative

3755 (65.7)

 

601 (58.4)

3154 (67.3)

 
  1. ART, anti-retroviral treatment; CIN, cervical intraepithelial neoplasia; IQR, inter-quartile range; VIA, visual inspection after acetic acid
  2. aThe number of women in levels of categorical variable may not add up to total “n” because missing category has been removed
  3. bFor p < 0.05
  4. cFor HIV positive patients only